Publications
- Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders2019 | Faculty of Medicine in Hradec Králové
- Is percutaneous computed tomography-guided biopsy sufficient to establish indolent lymphoma transformation?2019 | Faculty of Medicine in Hradec Králové
- Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma2018 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
- Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance2018 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
- Treatment of repeatedly relapsing chronic lymphocytic leukemia2018 | Faculty of Medicine in Hradec Králové
- Treatment of Multifocal Multisystem BRAF Positive Langerhans Cell Histiocytosis with Cladribine, Surgery and Allogenic Stem Cell Transplantation2017 | Faculty of Medicine in Hradec Králové
- Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Practical approach to management of chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia2014 | Faculty of Medicine in Hradec Králové
Loading network view...
